ULS CME at Sea Educational Summary
This program in its entirety provides 12 contact hours over three mornings, of live AAFP/ AMA PRA Category 1 CreditACPE and pharmacology CE/ CME credit .
New Drugs Part 1, Obesity Case Studies, COPD, Fibromyalgia
New Drugs Part 2, Pediatric Pharmacotherapeutics, COVID –Drug Interactions, CKD Treatment in Primary Care
Antibiotic Update: Respiratory Infections, OA and RA Guidelines 2023, Immuniizations
Bonus: Choose any 5 hour ULS on demand or live stream course at no charge
ULS CME at Sea Cruise Summary
Get ready for a perception remixing, memory maxing mic drop — the new Symphony of the Seas® is all that and more. It’s your favorite onboard hits, including the ten-story test of courage, Ultimate Abyss℠ and twin FlowRider® surf simulators, plus revolutionary new firsts, like glow-in-the-dark laser tag. And deck-defying attractions aren’t the only things to look forward to when you sail onboard this Oasis Class ship. Symphony of the Seas® is also loaded with delicious new ways to tempt your taste buds — like the gameday game changing Playmakers℠ Sports Bar & Arcade — and larger-than-life ways to stay, like the Ultimate Family Suite. Go get your thrill on.
Day 1 - Miami, Florida - Departs 4 PM
Day 2 - Perfect Day at CocoCay, Bahamas - Arrives 7:00 AM - Departs 4:00 PM
Day 3 - International Date Line-at sea (seminar day)
Day 4 - Charlotte Amalie, St. Thomas -Arrives 12:30 PM- Departs 7:00 PM
Day 5 - Philipsburg, St. Maarten - Arrives 8:00 AM- Departs 6:00 PM
Day 6 -At sea (seminar day)
Day 7 -At sea (seminar day)
Day 8- Miami, Florida Disembarkation
-
New Drugs Part 1, Obesity Case Studies, COPD, Fibromyalgia
At the completion of this activity, the participant will be able to:
New Drugs Part 1
1) Identify 10 – 20 new medications
2) Discuss the use, side effects, drug-drug interactions, and benefits of each of the medications.
3) Discuss updates related to labeling, indications, risks associated with various medications
Obesity Case Studies:
4) Discuss the health risks associated with obesity
5) Identify the various behavioral modalities utilized to assist with weight loss
6) Discuss pharmacologic strategies for weight stabilization or loss in the overweight or obese individual
COPD
7) Identify statistics regarding COPD.
8) Discuss the signs and symptoms of COPD.
9) Discuss treatment options for COPD .
Fibromyalgia
10) Identify new diagnostic criteria for fibromyalgia .
11) Discuss the various non-pharmacologic and pharmacologic treatments available for individuals with fibromyalgia
12) Review multimodal treatments based upon the evidence .
-
New Drugs Part 2, Pediatric Pharmacotherapeutics, Chronic Kidney Disease (CKD) Treatment in Primary Care
At the completion of this activity, the participant will be able to:
New Drugs Part 2
1) Identify 10 – 20 new medications
2) Discuss the use, side effects, drug-drug interactions, and benefits of each of the medications.
3)Discuss updates related to labeling, indications, risks associated with various medications.
Pediatric Pharmacotherapeutics:
4)Identify ways in which children are different than adults in terms of pharmacotherapeutics .
5) Discuss common pediatric prescribing errors.
6)Discuss strategies to prevent pediatric prescribing errors.
7) Identify medications with new pediatric approvals.
CKD Treatment in Primary Care
8) Detect and recognize CKD in patients with reduced kidney function, including in early stages of disease.
9) Implement screening for albuminuria in patients with diabetes in clinical practice to identify CKD as early as possible.
10) Initiate therapy with evidence-based therapies, including newer agents, for patients with CKD when indicated.
-
Antibiotic Update: Respiratory Infections, OA and RA Guidelines 2023, Immunizations
At the completion of this activity, the participant will be able to:
Antibiotic Update: Respiratory Infections:
1) Identify statistics related to incidence/prevalence of various respiratory conditions.
2) Discuss the signs and symptoms of pneumonia, ABRS, AOM, AECB.
3) Discuss treatment pharmacologic options for the above conditions.
OA and RA Guidelines 2023:
4) Discuss the pathophysiology of osteoarthritis and rheumatoid arthritis.
5) Identify the non-pharmacologic and pharmacologic agents available for the treatment of osteoarthritis and RA.
6) Compare and contrast newer pharmacologic agents with older agents with regard to benefits, risks, side effects, and drug interactions.
Immunizations:
7) Identify the 2024 recommended vaccinations and schedule for individuals across the lifespan.
8) Discuss the benefits and side effects of the various vaccines for individuals across the lifespan.
9) Discuss strategies to improve vaccine hesitancy.
ULS CME at Sea Conference Credit
PHARMACISTS
University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. These programs are accredited for pharmacists.
Session 1: 4 Contact Hours ACPE UAN 0741-0000-25-001-L01-P, Knowledge
Session 2: 4 Contact Hours ACPE UAN 0741-0000-25-002-L01-P, Application
Session 3: 4 Contact Hours ACPE UAN 0741-0000-25-003-L01-P, Application
NURSE PRACTITIONERS/ NURSES: This course provides 12 contact hours to fulfill the pharmacotherapeutics/ pharmacology requirements for American Nurses Credentialing Center (ANCC) Category 1 Continuing Education Hours for certification renewal. The same hours submitted to renew certification may be submitted to a State Board of Nursing for re-licensure. American Nurses Credentialing Center (ANCC) accepts formally approved continuing education sponsored by organizations accredited or approved by the Accreditation Council for Pharmacy Education (ACPE). .
PHYSICIANS: The AAFP has reviewed 7 Night Eastern Caribbean & Perfect Day Cruise, January 19-26, 2025, Symphony of the Seas and deemed it acceptable for up to 12.00 Live AAFP Prescribed credit(s). Term of Approval is from 01/19/2025 to 01/26/2025. Physicians should claim only the credit commensurate with the extent of their participation in the activity. AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1. CME programs approved by the AAFP are eligible for Category 2 credit (or Category 1-A under special circumstances) through the American Osteopathic Association (AOA).
PHYSICIAN ASSISTANTS: American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for Prescribed credit from AAFP. Physician assistants may report the number of hours stated above of Category I credit for completing this program.
CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.
CANADIAN PHARMACISTS: Canadian Council on Continuing Education in Pharmacy (CCCEP) accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE). This credit is applicable to health professionals who may require pharmacology credit.
CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive up to 10 MAINPRO-M1 credits for participation in this activity due to reciprocal agreement with the American Academy of Family Physicians.
OTHER HEALTH PROFESSIONALS: Contact your respective board regarding approval
Conference Registration Fees
Option |
Advanced Registration until October 19, 2024 |
Regular Registration |
Physicians and Dentists |
$895 | $945 |
Physician Assistants |
$695 | $745 |
Nurses, Residents, Students |
$495 | $545 |
Conference Policies - Please review before registering.
Conference registration includes workshop attendance, handouts and refreshments during the meetings and documentation of continuing education credit*. Spouses, family and friends are welcome and do not need to register unless they attend the educational sessions. Special conference fees are available for non-professional accompanying persons who wish to attend one or more session (no special receipt, certification or credit issued).
ULS CME at Sea Cruise Registration Fees
All rates are per person based on double occupancy.
Interior Stateroom Category 4V: $873
Ocean View Category 4N : $1022
Ocean View Balcony 4D $1234
Refundable Deposit: 20% of cruise fare, per person.
Cancellation Policy: Cancellation policies vary by cruise line, itinerary and length of cruise. When reserving your stateroom, please review the policy applicable to this cruise with University at Sea staff.
How to Book ULS CME at Sea Cruise
To attend the conference, participants must book their cruise through Continuing Education, Inc.. This ensures the company can provide full conference services and complimentary social amenities to all meeting participants and their guests. Note also, that participants' family and friends are welcome to book within our group to take advantage of our typically excellent cruise rates. Thank you for your cooperation.
Cruise Reservations Contact:
University at Sea: 1-800-926-3775.
Final deposit due October 19, 2024
Conference attendees who book outside of this group will be charged a $300/cabin surcharge at time of registration.
https://www.continuingeducation.net/coursedescription.php?program_number=3806#description
ULS CME at Sea Quick Facts
Prices are per person, based on double occupancy
Per Person CRUISE plus Taxes & Fees $185.38 per person
Cruise line reserves the right to impose a fuel surcharge up to $10/ day.
Rate includes: 5 Star ship, all meals-unlimited gourmet dining, and entertainment each evening.,
Passport required
Refundable deposit of $250 perperson is due at time of booking.
Make Cruise Reservations: with Continuing Education Inc: 800-926-3775
Attendees who do not book withContinuing Education Inc/University at Sea will be charged $300/cabin surcharge at point of registration.
Airfare and roundtrip transfers are additional.
Prices are subject to change without notice.
Final payment due by October 19, 2024